ruthenium has been researched along with Acute Myelogenous Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Buske, C; Chakrabortty, S; Feuring-Buske, M; Kuan, SL; Rau, S; Rawat, VPS; Sieste, S; Stumper, A; Vegi, NM; Weil, T; Zegota, MM | 1 |
1 other study(ies) available for ruthenium and Acute Myelogenous Leukemia
Article | Year |
---|---|
Somatostatin receptor mediated targeting of acute myeloid leukemia by photodynamic metal complexes for light induced apoptosis.
Topics: Adult; Aged; Apoptosis; Cell Line, Tumor; Drug Stability; Female; Fetal Blood; Humans; Leukemia, Myeloid, Acute; Lysosomes; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Receptors, Somatostatin; Ruthenium; Somatostatin | 2020 |